No. 1 (46) (2022)

Published: 2022-05-26

Review

The place of a fixed combination of rosuvastatin and fenofibrate in the treatment of patients with combined atherogenic dyslipidemia

A. G. Obrezan, M. V. Ezhov, I. V. Sergienko, A. S. Alieva, V. S. Gurevich

5-23
- PDF (Русский)
Statin intolerance

A. B. Sumarokov

24-30
- PDF (Русский)
Unsolved problems of dyslipidemia and residual cardiovascular risk

V. S. Gurevich, N. A. Koziolova, M. V. Ezhov, I. V. Sergienko, A. S. Alieva, T. V. Vavilova, A. V. Panov, A. G. Obrezan, V. Yu. Kalashnikov, G. P. Arutyunov, V. O. Konstantinov

31-39
- PDF (Русский)

Original research paper

Lipoprotein subfractions in patients with various cardiovascular risk

E.A. Utkina, N.V. Artemieva, M.V. Ezhov, O.I. Afanasyeva, S.N. Pokrovsky
Asymmetric dimethylarginine as a laboratory criterion after corrective therapy in patients with ascending thoracic aortic aneurysm

T. F. Subbotina, N. D. Gavrilyuk, T. A. Druzhkova, O. B. Irtyuga, V. E. Uspenskiy, O. M. Moiseeva, A. A. Zhloba

40-46
- PDF (Русский)
Low blood adiponectin level as a risk factor for severe coronary heart disease

E. A. Polyakova

47-56
- PDF (Русский)
Lipoproteid subfractions in patients with various cardiovascular risk

E. A. Utkina, N. V. Artemieva, M. V. Ezhov, O. I. Afanasieva, S. N. Pokrovsky

57-63
- PDF (Русский)

Discussions

Actual questions of intensiﬁcation of lipid-lowering therapy

Resolution of the National Scientific Council of Experts

64-70
- PDF (Русский)